Product image of Moxifloxacino Qualigen (Moxifloxacin) supplied by GNH India

Moxifloxacino Qualigen

Active Ingredient:
Moxifloxacin
Origin:
EU

Moxifloxacino Qualigen (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxifloxacino Qualigen, is a fluoroquinolone presented as an oral dosage form for systemic use. It treats a range of bacterial infections, particularly respiratory and skin infections, in adult patients as prescribed by a healthcare professional.

GNH India supplies Moxifloxacino Qualigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Neuraxpharm Spain, S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Moxifloxacino Qualigen is a fluoroquinolone antibacterial that targets bacterial DNA replication in several infection categories.
  • Community‑acquired bacterial pneumonia: effective in eradicating the causative pathogens and improving respiratory function.
  • Acute bacterial sinusitis: reduces sinus inflammation and clears infection.
  • Acute bacterial exacerbation of chronic bronchitis: shortens symptom duration and prevents further lung damage.
  • Skin and soft‑tissue infections: eliminates susceptible bacteria and promotes wound healing.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By blocking these targets, the drug prevents bacterial DNA synthesis and transcription, leading to bactericidal activity against a broad spectrum of Gram‑positive and Gram‑negative organisms.

Side Effects

Moxifloxacino Qualigen may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea
  • Diarrhea
  • Headache
  • Dizziness
  • Rash
  • Abdominal pain

Serious or Rare Side Effects

  • Tendon rupture or inflammation
  • QT interval prolongation leading to arrhythmia
  • Severe allergic reactions such as anaphylaxis
  • Clostridioides difficile‑associated colitis
  • Hepatic dysfunction
  • Photosensitivity

Precautions & Warnings

  • Before prescribing Moxifloxacino Qualigen, clinicians should consider several safety factors.
  • Renal impairment: adjust therapy based on renal function.
  • History of tendon disorders: avoid use due to risk of tendon rupture.
  • Cardiac arrhythmias: monitor QT interval, especially with other QT‑prolonging agents.
  • Concomitant antacids or supplements containing aluminum, magnesium, calcium, or iron: separate dosing to ensure absorption.
  • Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Moxifloxacino Qualigen can interact with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Other fluoroquinolones or QT‑prolonging drugs: additive risk of cardiac arrhythmia.
  • Warfarin: may increase anticoagulant effect and bleeding risk.
  • Theophylline: can raise serum theophylline concentrations.
  • Antacids containing aluminum or magnesium: significantly reduce moxifloxacin absorption.

Moderate Interactions (Monitor Closely)

  • NSAIDs: heightened risk of central nervous system stimulation.
  • Corticosteroids: increased likelihood of tendon injury.
  • Oral hypoglycemic agents: possible alterations in blood glucose control.

Frequently Asked Questions

Moxifloxacino Qualigen is indicated for adult patients with community‑acquired bacterial pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and skin or soft‑tissue infections caused by susceptible bacteria. The drug is prescribed when a fluoroquinolone is appropriate based on the infection type and microbial susceptibility.

Moxifloxacin blocks bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes required for DNA supercoiling and replication. Inhibiting these targets halts bacterial DNA synthesis and transcription, leading to rapid bacterial cell death and a broad‑spectrum bactericidal effect.

The dosage regimen for Moxifloxacino Qualigen is determined by the prescribing clinician based on the specific infection, patient characteristics, and local guidelines. Healthcare providers set the dose, frequency, and duration of therapy to achieve optimal clinical outcomes.

Safety data for moxifloxacin in pregnancy and lactation are limited. The drug should be used only if the potential benefit justifies any possible risk to the fetus or infant. Clinicians must evaluate each case individually and discuss alternatives when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain needs), and necessary import documentation.

Moxifloxacin offers a broader spectrum against Gram‑positive organisms and enhanced activity in respiratory infections compared with older fluoroquinolones such as ciprofloxacin. It also has a longer half‑life, allowing once‑daily dosing, but shares class‑related safety considerations like QT prolongation and tendon‑related risks.

Store the product at room temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight, and excessive heat. Do not refrigerate or freeze the tablets, and ensure the container remains tightly closed to maintain stability.

Moxifloxacino Qualigen is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid simultaneous intake of antacids or supplements containing aluminum, magnesium, calcium, or iron, as these may reduce absorption.

Serious adverse events include tendon rupture or tendinitis, QT interval prolongation that can lead to arrhythmias, severe hypersensitivity reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis. Patients should be instructed to report any sudden joint pain, palpitations, or severe skin reactions promptly.

Moxifloxacino Qualigen is contraindicated in individuals with a known hypersensitivity to moxifloxacin or other fluoroquinolones. It should also be avoided in patients with a history of tendon disorders related to fluoroquinolone use, those with established prolonged QT interval, and in patients receiving concurrent medications that strongly prolong QT without careful monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT